01/08/2025 | Press release | Distributed by Public on 01/08/2025 06:48

Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T Cell Engagers VIR 5818 in Solid Tumors and VIR 5500 in mCRPC

Please select the service you want to use:

• Newsvine
• Digg
• Delicious
• StumbleUpon
• Technorati
• Buzz
• Favorites
• Google Reader

 Back

 Download the original document